سوق منتجات جفاف العين – المحركات والاتجاهات والفرص وإحصاءات النمو | 2031

  • Report Code : TIPRE00012323
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 217
Buy Now

من المتوقع أن ينمو حجم سوق منتجات جفاف العين من 6.95 مليار دولار أمريكي في عام 2023 إلى دولار أمريكي 10.04 مليارمليار بحلول عام 2031، مسجلاً معدل نمو سنوي مركب قدره 4.7% خلال الفترة 2023-2031.

يتضمن التقرير آفاق النمو بسبب اتجاهات سوق منتجات جفاف العين الحالية وتأثيرها المتوقع خلال الفترة المتوقعة. جفاف العين هو حالة تتميز بعدم وجود نوعية كافية من الدموع لتليين وتغذية العين أو عن طريق التبخر السريع للدموع. مع التغيرات الهرمونية، مع تقدم الأشخاص في السن، يقل الميل إلى إنتاج الدموع. جفاف العين أمر شائع في كل من الذكور والإناث. ومع ذلك، يتم تسجيل المزيد من الحالات لدى النساء، وخاصة أولئك الذين مروا بفترة انقطاع الطمث. جفاف العين هو حالة مزمنة ليس لها علاج محدد، ولكن العلاجات يمكن أن تساعد في إدارة الأعراض. من المتوقع أن توفر البلدان النامية فرص نمو كبيرة لسوق منتجات جفاف العين في السنوات القادمة.

محركات النمو:

يؤدي الارتفاع الكبير في عدد السكان المسنين إلى نمو سوق منتجات جفاف العين

متلازمة جفاف العين هي اضطراب شائع في العين يؤثر على نسبة كبيرة من السكان، وخاصة أولئك الذين تزيد أعمارهم عن 50 عامًا. ويعد الأشخاص في منتصف العمر وكبار السن أهدافًا أكثر شيوعًا لهذه المتلازمة، والتي يمكن أن ترتبط مع استخدام العدسات اللاصقة، وانتشار أمراض المناعة الذاتية، وتأثيرات الأدوية الجهازية، والعمليات الجراحية الانكسارية. وسيستمر عبء متلازمة العين الجافة في الارتفاع بسبب زيادة متوسط العمر المتوقع، إلى جانب ارتفاع الحالات بين كبار السن. ووفقاً لمنظمة الصحة العالمية، فإن عدد السكان الذين تبلغ أعمارهم 60 عاماً فما فوق سيرتفع من مليار نسمة في عام 2020 إلى 1.4 مليار نسمة بحلول عام 2030؛ ومن المرجح أن يتضاعف العدد ليصل إلى 2 مليار بحلول عام 2050. ومن المتوقع أن يتضاعف عدد الأفراد الذين تبلغ أعمارهم 80 عامًا فما فوق ثلاث مرات من عام 2020 إلى عام 2050 ليصل إلى 426 مليونًا. وفقا لمقالة نشرتها الأكاديمية الأمريكية لطب العيون، فإن خطر الإصابة بـ DED يزداد مع تقدم العمر. يتراوح معدل انتشار مرض الـ DED من 2.7% لدى الأفراد الذين تتراوح أعمارهم بين 18-34 عامًا إلى 18.6% لدى الأشخاص الذين تبلغ أعمارهم 75 عامًا فما فوق. تشير مراكز السيطرة على الأمراض والوقاية منها (CDC) إلى أن معدل انتشار اعتلال الشبكية السكري في الولايات المتحدة كان الأدنى بين الأشخاص الذين تقل أعمارهم عن 25 عامًا (13.0٪) والأعلى بين الأشخاص من الفئة العمرية 65-79 (28.4٪). وبالتالي، فإن الطلب على منتجات جفاف العين مثل الدموع الاصطناعية يتزايد مع تزايد عدد كبار السن في جميع أنحاء العالم.

رؤى استراتيجية يمكنه مساعدة أصحاب المصلحة في هذا السوق على التخطيط لاستراتيجيات النمو الخاصة بهم. شركة سانتن للأدوية المحدودة، جونسون آند أمب؛ تعد شركة Johnson وOASIS Medical وURSAPHARM Arzneimittel GmbH وRohto Pharmaceutical Co Ltd وOCuSOFT Inc وBausch Health Companies Inc وAbbVie Inc وPrestige Consumer Healthcare Inc وFarmigea SpA وAlcon AG من بين الشركات البارزة المتخصصة في منتجات جفاف العين. تقرير السوق. تركز هذه الشركات على تطوير تقنيات جديدة، وتحديث المنتجات الحالية، وتوسيع تواجدها الجغرافي لتلبية الطلب الاستهلاكي المتزايد في جميع أنحاء العالم. وفقًا للبيانات الصحفية للشركة، فيما يلي بعض التطورات الأخيرة التي قامت بها الشركات الكبرى في السوق:

    •في سبتمبر 2023، شركة Bausch + Lomb Corporation (Bausch + Lomb)، وهي شركة تابعة لشركة Bausch Health Companies Inc، أكملت استحواذها على XIIDRA (محلول العيون lifetegrast) 5٪، وهي قطرة عين غير الستيرويد معتمدة خصيصًا لعلاج علامات وأعراض مرض جفاف العين. يركز المنتج بشكل خاص على الالتهاب المرتبط بجفاف العين وبعض أصول طب العيون الأخرى.•في تشرين الثاني (نوفمبر) 2022، أطلقت شركة Santen Pharmaceutical Co Ltd شركة DIQUAS LX Ophthalmic Solution 3% (ديكوافوسول الصوديوم) في اليابان. محلول DIQUAS LX عبارة عن تركيبة تتطلب استخدام قطرة واحدة ثلاث مرات يوميًا لعلاج مرض جفاف العين.•في أغسطس 2022، أبرمت شركة Alcon وAerie Pharmaceuticals Inc.‎ اتفاقية اندماج نهائية. وكجزء من هذه الصفقة، استحوذت شركة Alcon على شركة Aerie. تساعد هذه الصفقة في تعزيز تواجد Alcon في مجال أدوية العيون من خلال محفظتها المتنامية من المنتجات التجارية وخط التطوير.•في يوليو 2021، استحوذت شركة Prestige Consumer Healthcare على TheraTears Inc.. أضاف الاستحواذ على TheraTears إلى محفظة Prestige الرائدة في مجال العناية بالعيون وزود الشركة بآفاق نمو جديدة على المدى الطويل.•في فبراير 2021، أطلقت Allergan Refresh Digital، وهي قطرة جديدة من مواد التشحيم للعين مصممة خصيصًا تخفيف الجفاف والتهيج الناتج عن قضاء وقت طويل أمام الشاشة.•في يونيو 2020، أبرمت شركة OCuSOFT Inc. وشركة EKKDA Research LLC اتفاقية توزيع المبيعات. تساعد هذه الشراكة الشركاء على تأسيس وتطوير الأعمال المتعلقة بطب العيون وقياس البصر. تركز مشاريع شركة EKKDA البحثية ذات المسؤولية المحدودة بشكل أساسي على العناية بالعيون.•في مايو 2020، استحوذت شركة AbbVie Inc على شركة Allergan plc كجزء من استراتيجية الأعمال غير العضوية للشركة. أتاحت عملية الاستحواذ للشركة إمكانية الوصول إلى محفظة أعمالها وتوسيعها في الأسواق المرتبطة بالعناية بالعيون.•في يناير 2020، قامت شركة Santen Pharmaceutical Co Ltd، كجزء من توسع أعمالها في الصين، ببناء مصنعها الثاني لـ فرعها الصيني "Santen Pharmaceutical (China) Co Ltd." لدعم الطلب المتزايد على المنتجات في الصين.

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which distribution channel segment is dominating the dry eye products market?

The dry eye products market by distribution channel, is categorized into retail pharmacies, hospital pharmacies, and online pharmacies. The retail pharmacies segment held the largest dry eye products market share in 2023. The online pharmacies segment is anticipated to register the highest CAGR of 5.7%.

Which region is the fastest growing the dry eye products market?

Asia Pacific is expected to be the fastest growing region in the dry eye products market. The dry eye products market in Asia Pacific is expected to register the highest CAGR during the forecast period. According to NIH, in China, ~20–30% of people are diagnosed with dry eye conditions every year. The dry eye products market in China is quite competitive, with the presence of both domestic and international pharmaceutical companies. Novaliq has established a strategic cooperation with Jiangsu Hengrui Pharmaceuticals to manufacture, develop, and commercialize NOV03 for the treatment of dry eye disease.

Which product segment is dominating the dry eye products market?

The dry eye products market, based on product, is segmented into artificial tears, anti-inflammatory drugs, punctal plugs, secretagogues, oral omega supplements, and others. The artificial tears segment held the largest dry eye products market share in 2023. The anti-inflammatory drugs segment is anticipated to register the highest CAGR during 2023–2031.

Which dosage form segment is dominating the dry eye products market?

The dry eye products market by dosage form is bifurcated into OTC and prescription. The OTC segment held a larger share of the market in 2023, and it is anticipated to register a higher CAGR of 5.1% during 2023–2031.

What are the driving factors for the dry eye products market across the globe?

The factors that are driving growth of the market are the rising prevalence of dry eye and upsurge in geriatric population.

What are dry eye products?

Dry eye is a condition characterized by the lack of adequate quality of tears to lubricate and nourish the eye or by a quick evaporation of tears. With hormonal changes, as people get older, the tendency to produce tears decreases. Dry eye is common in both males and females. However, more cases are recorded in women, mainly those who have gone through menopause. Dry eye is a chronic condition that doesn’t have a specific cure, but treatments can help manage the symptoms.

Who are the major players in the dry eye products market?

The dry eye products market majorly consists of the players such as Santen Pharmaceutical Co Ltd, Johnson & Johnson, OASIS Medical, URSAPHARM Arzneimittel GmbH, Rohto Pharmaceutical Co Ltd, OCuSOFT Inc, Bausch Health Companies Inc, AbbVie Inc, Prestige Consumer Healthcare Inc, Farmigea SpA and Alcon AG.

Which country is dominated the dry eye products market?

US holds the largest market share in dry eye products market. DED is a common but underdiagnosed condition in the US, and an increase in the population age can be associated with the surging prevalence of this disease. According to the Centers for Disease Control and Prevention (CDC), age-related eye diseases such as cataract, macular degeneration, diabetic retinopathy, and glaucoma are the primary causes of blindness and impaired vision in the US. Other common eye disorders include amblyopia and strabismus. Dry eye disease is expected to affect as many as 2.79 million US men by 2030.

The List of Companies - Dry Eye Products Market

  1. Santen Pharmaceutical Co., Ltd.
  2. Johnson & Johnson
  3. OASIS Medical
  4. URSAPHARM Arzneimittel GmbH
  5. Rohto Pharmaceutical Co Ltd
  6. OCuSOFT Inc.
  7. Bausch Health Companies Inc
  8. AbbVie Inc
  9. Prestige Consumer Healthcare Inc.
  10. Farmigea SpA
  11. Alcon AG

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports